Therefore, several molecular tests for adjustment of cytological diagnosis of thyroid nodules have been proposed, which included panel of somatic mutations (e.g., BRAF and NRAS mutation and/or RET/PTC translocation) and immunocytochemistry tests based on gene expression signatures. The gene discussed is NRAS; the disease is thyroid nodule.